Glimpse was founded on the premise that the battery industry has spent the last two decades focusing on scaling up cell production facilities and rapidly improving cell performance, while relying on an insufficient set of quality control tools.
A wide range of cell defects aren’t detectable with electrochemical tests, which the industry has primarily been relying on to distinguish bad from good cells.
An electric vehicle carrying a defective cell may drive smoothly for several thousand miles before any indication of pack failure emerges.
Just like raw materials or production capacity, we see battery quality as a major bottleneck to the electrification of everything - one that is underestimated and underserved.

Patrick, Peter and Eric spent a combined 25 years in the Li-ion battery industry. Whether they were working for cell producers or electric vehicle makers, every time they faced a cell quality challenge, they systematically turned to the same technology for answers: X-ray computed tomography (CT) scanning.
When they realized how scalable CT scanning could be, they co-founded Glimpse to turn what is currently a low-volume, costly lab instrument into the world’s most powerful battery quality monitoring platform.
